GPCR Perspectives & Challenges in the Development of Radioligand Therapies – RLT for Nuclear Oncology
Time: 9:30 am
day: Conference Day Two
Details:
- The therapeutic roles of GPCRs in the innovation of RLT for nuclear oncology
- What are the key focal points in novel RLT developments
- Why peptides are the most attractive ligands for RLT
